Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice

Por Kitagaki, K, Businga, T R, Kline, J N
Publicado em 2006

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study

Por Silkoff, P. E., Laviolette, M., Singh, D., FitzGerald, J. M., Kelsen, S., Backer, V., Porsbjerg, C., Girodet, P. O., Berger, P., Kline, J. N., Khatri, S., Chanez, P., Susulic, V. S., Barnathan, E. S., Baribaud, F., Loza, M. J.
Publicado no Respir Res (2016)

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study

Por Silkoff, P. E., Strambu, I., Laviolette, M., Singh, D., FitzGerald, J. M., Lam, S., Kelsen, S., Eich, A., Ludwig-Sengpiel, A., hupp, G. C, Backer, V., Porsbjerg, C., Girodet, P. O., Berger, P., Leigh, R., Kline, J. N., Dransfield, M., Calhoun, W., Hussaini, A., Khatri, S., Chanez, P., Susulic, V. S., Barnathan, E. S., Curran, M., Das, A. M., Brodmerkel, C., Baribaud, F., Loza, M. J.
Publicado no Respir Res (2015)